MiRNA Dysregulation in Childhood Hematological Cancer

Int J Mol Sci. 2018 Sep 10;19(9):2688. doi: 10.3390/ijms19092688.

Abstract

For decades, cancer biology focused largely on the protein-encoding genes that have clear roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome instability, drug resistance, or signaling pathways that stimulate growth, angiogenesis, or metastasis. MicroRNAs (miRNAs), however, represent one of the more abundant classes of cell modulators in multicellular organisms and largely contribute to regulating gene expression. Many of the ~2500 miRNAs discovered to date in humans regulate vital biological processes, and their aberrant expression results in pathological and malignant outcomes. In this review, we highlight what has been learned about the roles of miRNAs in some of the most common human pediatric leukemias and lymphomas, along with their value as diagnostic/prognostic factors.

Keywords: cancer; children; leukemia; lymphoma; miRNA; review.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Child
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Hematologic Neoplasms / genetics*
  • Humans
  • MicroRNAs / genetics*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • MicroRNAs